Searching for biomarkers in the progression from polycystic ovary syndrome to endometrial carcinoma

Background: Polycystic ovary syndrome is a female reproductive system disease closely related to endocrine and highly correlated with the development of endometrial carcinoma in women, it is important to identify the key genes involved in the development of polycystic ovary syndrome. Methods: To ide...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhenzhen Lu, Ying Gao
Format: Article
Language:English
Published: IMR Press 2021-10-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/48/5/10.31083/j.ceog4805180
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850256089072795648
author Zhenzhen Lu
Ying Gao
author_facet Zhenzhen Lu
Ying Gao
author_sort Zhenzhen Lu
collection DOAJ
description Background: Polycystic ovary syndrome is a female reproductive system disease closely related to endocrine and highly correlated with the development of endometrial carcinoma in women, it is important to identify the key genes involved in the development of polycystic ovary syndrome. Methods: To identify the hub genes, microarray datasets GSE48301, GSE115810 and GSE3013 were downloaded from Gene Expression Omnibus database. We performed in-depth cross-tabulation bioinformatic analysis to identify differentially expressed genes (DEGs) among four types of endometrial cells in GSE48301 and two endometrial carcinoma datasets GSE115810 and GSE3013, followed by gene ontology, KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway enrichment, protein-protein interaction network analysis. Results: Thirteen seed DEGs and 4 significantly expressed DEGs were identified, and potential drugs and mRNAs were found. Conclusion: EDNRA, FBN1, PMP22, SPARC and IGF-1 may be potential and their miRNAs, especially hsa-miR-29a-3p and hsa-miR-29b-3p may be potential biomarkers in the progression from PCOS to endometrial carcinoma.
format Article
id doaj-art-50716dfb792f445b899d8f131900a7e0
institution OA Journals
issn 0390-6663
language English
publishDate 2021-10-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj-art-50716dfb792f445b899d8f131900a7e02025-08-20T01:56:42ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632021-10-014851117112510.31083/j.ceog4805180S0390-6663(21)00019-1Searching for biomarkers in the progression from polycystic ovary syndrome to endometrial carcinomaZhenzhen Lu0Ying Gao1Department of Gynaecology and Obstetrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022 Wuhan, Hubei, ChinaDepartment of Gynaecology and Obstetrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022 Wuhan, Hubei, ChinaBackground: Polycystic ovary syndrome is a female reproductive system disease closely related to endocrine and highly correlated with the development of endometrial carcinoma in women, it is important to identify the key genes involved in the development of polycystic ovary syndrome. Methods: To identify the hub genes, microarray datasets GSE48301, GSE115810 and GSE3013 were downloaded from Gene Expression Omnibus database. We performed in-depth cross-tabulation bioinformatic analysis to identify differentially expressed genes (DEGs) among four types of endometrial cells in GSE48301 and two endometrial carcinoma datasets GSE115810 and GSE3013, followed by gene ontology, KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway enrichment, protein-protein interaction network analysis. Results: Thirteen seed DEGs and 4 significantly expressed DEGs were identified, and potential drugs and mRNAs were found. Conclusion: EDNRA, FBN1, PMP22, SPARC and IGF-1 may be potential and their miRNAs, especially hsa-miR-29a-3p and hsa-miR-29b-3p may be potential biomarkers in the progression from PCOS to endometrial carcinoma.https://www.imrpress.com/journal/CEOG/48/5/10.31083/j.ceog4805180differentially expressed genesendometrial carcinomainsulin-like growth factor 1polycystic ovary syndrome
spellingShingle Zhenzhen Lu
Ying Gao
Searching for biomarkers in the progression from polycystic ovary syndrome to endometrial carcinoma
Clinical and Experimental Obstetrics & Gynecology
differentially expressed genes
endometrial carcinoma
insulin-like growth factor 1
polycystic ovary syndrome
title Searching for biomarkers in the progression from polycystic ovary syndrome to endometrial carcinoma
title_full Searching for biomarkers in the progression from polycystic ovary syndrome to endometrial carcinoma
title_fullStr Searching for biomarkers in the progression from polycystic ovary syndrome to endometrial carcinoma
title_full_unstemmed Searching for biomarkers in the progression from polycystic ovary syndrome to endometrial carcinoma
title_short Searching for biomarkers in the progression from polycystic ovary syndrome to endometrial carcinoma
title_sort searching for biomarkers in the progression from polycystic ovary syndrome to endometrial carcinoma
topic differentially expressed genes
endometrial carcinoma
insulin-like growth factor 1
polycystic ovary syndrome
url https://www.imrpress.com/journal/CEOG/48/5/10.31083/j.ceog4805180
work_keys_str_mv AT zhenzhenlu searchingforbiomarkersintheprogressionfrompolycysticovarysyndrometoendometrialcarcinoma
AT yinggao searchingforbiomarkersintheprogressionfrompolycysticovarysyndrometoendometrialcarcinoma